The current trading zone is interesting to the point that investors should pay attention to the stock and anticipate a return of the underlying upward trend. Investors have an opportunity to buy the stock and target the € 244.4.
The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
The company has solid fundamentals for a short-term investment strategy.
The company is in a robust financial situation considering its net cash and margin position.
The group usually releases upbeat results with huge surprise rates.
The stock, which is currently worth 2021 to 0.31 times its sales, is clearly overvalued in comparison with peers.
Its low valuation, with P/E ratio at 8.13 and 7.17 for the ongoing fiscal year and 2022 respectively, makes the stock pretty attractive with regard to earnings multiples.
This company will be of major interest to investors in search of a high dividend stock.
Sales forecast by analysts have been recently revised upwards.
For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
Analysts covering this company mostly recommend stock overweighting or purchase.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The stock is in a well-established, long-term rising trend above the technical support level at 176.64 EUR
ę MarketScreener.com 2021
Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.